Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., Friday expanded eligibility for COVID-19 booster shots to include all adults aged 18 and older who received a second dose of the Pfizer or Moderna vaccine at least six months ago, as recommended by the agency’s Advisory Committee on Immunization Practices.

“Booster shots have demonstrated the ability to safely increase people’s protection against infection and severe outcomes and are an important public health tool to strengthen our defenses against the virus as we enter the winter holidays,” Walensky said. 

CDC said it continues to encourage the 47 million adults who are not yet vaccinated to get vaccinated as soon as possible to protect themselves, their loved ones and communities. 

“We also strongly encourage those who were already eligible ¬— older populations and individuals with underlying medical conditions¬ ¬— to get boosted before the holidays,” the agency said.

The Food and Drug Administration Friday authorized a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older at least six months after receiving the initial two-dose series or two months after receiving the single-dose Johnson & Johnson vaccine. CDC’s ACIP then recommended a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older, based on individual benefit and risk, at least six months after receiving the initial two-dose series. 

Related News Articles

Headline
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection…
Headline
The Biden Administration today launched a six-week campaign to encourage Americans to get an updated COVID-19 vaccine. In addition to ongoing pop-up clinics,…
Headline
Children under age 5 are more likely to receive a COVID-19 vaccine if their parents perceive it as safe and their health care provider recommends it, according…
Headline
AHA this week released a new Thanksgiving-focused toolkit to help promote pediatric COVID-19 vaccination on social media, including sample content and graphics…
Headline
The Food and Drug Administration recently updated its health care provider fact sheet on bebtelovimab to note that the monoclonal antibody is not expected…
Headline
Black patients who sought outpatient care for COVID-19 between January and July 2022 were 36% less likely than white patients to receive the antiviral pill…